SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318154-17-000027
Filing Date
2017-10-26
Accepted
2017-10-25 20:00:14
Documents
72
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amgn-2017930x10q.htm 10-Q 1901792
2 RULE 13A-14(A) CERTIFICATIONS amgn-ex31_2017930xq3.htm EX-31 23712
3 SECTION 1350 CERTIFICATIONS amgn-ex32_2017930xq3.htm EX-32 10911
  Complete submission text file 0000318154-17-000027.txt   10405878

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT amgn-20170930.xml EX-101.INS 2966237
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amgn-20170930.xsd EX-101.SCH 59108
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amgn-20170930_cal.xml EX-101.CAL 81093
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amgn-20170930_def.xml EX-101.DEF 322689
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amgn-20170930_lab.xml EX-101.LAB 711279
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amgn-20170930_pre.xml EX-101.PRE 453244
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37702 | Film No.: 171154227
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1